Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Actas Dermo-Sifiliograficas
|
August 7, 2008
[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides]
S Pérez-Barrio, R Izu, J C García-Ruiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 11, 2020
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study
R Rivera, A Martorell, A López, et al.
British Journal of Cancer
|
September 6, 2000
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma
M D Boyano, M D Garcia-Vázquez, T López-Michelena, et al.
European Cytokine Network
|
December 23, 2000
Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours
M D García-Vázquez, M D Boyano, M L Cañavate, et al.
The British Journal of Dermatology
|
February 24, 2012
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
Y Peñate, B Hernández-Machín, L I Pérez-Méndez, et al.
Circulation Research
|
May 17, 2024
Association of Neighborhood and Environmental Factors With Clinical Phenotypes and Outcomes in Heart Failure With Preserved Ejection Fraction
David A Liem, Hitalo Silva, Erick Romero, et al.
The British Journal of Dermatology
|
April 26, 2019
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
J C Armario-Hita, J Pereyra-Rodriguez, J F Silvestre, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 9, 2019
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
R Fernández-de-Misa, B Hernández-Machín, A Combalía, et al.
Experimental Dermatology
|
July 31, 2024
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
B Butrón-Bris, M Llamas-Velasco, M C Ovejero-Benito, et al.
Actas Dermo-Sifiliograficas
|
February 23, 2024
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
R Izu-Belloso, I Gainza-Apraiz, P Ortiz-Romero, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Actas Dermo-Sifiliograficas
|
August 7, 2008
[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides]
S Pérez-Barrio, R Izu, J C García-Ruiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 11, 2020
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study
R Rivera, A Martorell, A López, et al.
British Journal of Cancer
|
September 6, 2000
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma
M D Boyano, M D Garcia-Vázquez, T López-Michelena, et al.
European Cytokine Network
|
December 23, 2000
Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours
M D García-Vázquez, M D Boyano, M L Cañavate, et al.
The British Journal of Dermatology
|
February 24, 2012
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
Y Peñate, B Hernández-Machín, L I Pérez-Méndez, et al.
Circulation Research
|
May 17, 2024
Association of Neighborhood and Environmental Factors With Clinical Phenotypes and Outcomes in Heart Failure With Preserved Ejection Fraction
David A Liem, Hitalo Silva, Erick Romero, et al.
The British Journal of Dermatology
|
April 26, 2019
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
J C Armario-Hita, J Pereyra-Rodriguez, J F Silvestre, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 9, 2019
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
R Fernández-de-Misa, B Hernández-Machín, A Combalía, et al.
Experimental Dermatology
|
July 31, 2024
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
B Butrón-Bris, M Llamas-Velasco, M C Ovejero-Benito, et al.
Actas Dermo-Sifiliograficas
|
February 23, 2024
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
R Izu-Belloso, I Gainza-Apraiz, P Ortiz-Romero, et al.
Page
of 4